98 results
S-8
EX-10.1
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
8 Jun 04
Registration of securities for employees
12:00am
,
partners, employees, agents and representatives who have (and only to the extent
such persons have) a legitimate need for access to such Confidential … Information
(the "Third Parties") in connection with the foregoing purposes. We will advise
all Third Parties having access to Confidential
8-K
EX-99.1
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
19 Nov 21
Cyclo Therapeutics Announces Pricing of $11.7 Million Underwritten Public Offering of Common stock
4:04pm
intravenously in Alzheimer’s Disease based on encouraging data from an Expanded Access program for late-onset Alzheimer’s Disease (NCT03624842). Additional
424B4
h5qnwh gcqihfelfjj
11 Dec 20
Prospectus supplement with pricing info
12:00am
8-K
EX-99.1
dkwv3p 5f9
11 Dec 20
Cyclo Therapeutics Announces Pricing of $12.5 Million Public Offering
4:02pm
424B4
wulfu 97zi3
11 Dec 20
Prospectus supplement with pricing info
1:38pm
425
EX-2.1
ucmz1pu9sc68s
21 Sep 23
Business combination disclosure
4:28pm
8-K
EX-2.1
5uoj 4i1ok3lb27vd8v9
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
4:28pm
8-K
EX-99.1
pz3 dhxb20
27 Dec 23
Completion of Acquisition or Disposition of Assets
8:25pm
8-K
EX-10.2
ex9lp
2 Mar 22
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.1
bgk7r5o au
2 Mar 22
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.3
1ph frb4zfhea3b
2 Mar 22
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.4
td9augcu
2 Mar 22
Departure of Directors or Certain Officers
4:30pm